Security key
22978P106
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 18,058,960
- Share change
- +723,240
- Total reported value
- $12,982,249
- Price per share
- $0.72
- Number of holders
- 52
- Value change
- +$519,709
- Number of buys
- 14
- Number of sells
- 16
Report period
Q3 2025
Institutions
52
Top holders
10
CUE full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Cue Biopharma, Inc. SEC filings
Cue Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22978P106
Recent filing periods:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.
13D/G
13F
3/4/5
Evidence coverage
50 holder rows
Latest evidence as of 30 Jun 2025.
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bleichroeder LP |
13D/G
13F
Company
|
10%
|
$5,269,789
6,127,662 shares
|
$0 | 19 Mar 2025 |
| Mark E. Strome |
13D/G
|
5%
|
$1,862,968
2,166,242 shares
|
$0 | 14 Nov 2022 |
| Slate Path Capital LP |
13D/G
|
1.4%
|
$790,199
918,836 shares
|
$0 | 31 Dec 2024 |
| GC Wealth Management RIA, LLC |
13F
Company
|
7.7%
|
$2,273,181
3,331,644 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
7.3%
|
$2,173,770
3,187,346 shares
|
— | 30 Jun 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.6%
|
$472,350
692,173 shares
|
— | 30 Jun 2025 |
| Robertson Stephens Wealth Management, LLC |
13F
Company
|
1.1%
|
$326,481
478,500 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
1%
|
$306,463
449,162 shares
|
— | 30 Jun 2025 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.75%
|
$221,366
324,584 shares
|
— | 30 Jun 2025 |
| UBS Group AG |
13F
Company
|
0.67%
|
$199,542
292,583 shares
|
— | 30 Jun 2025 |
| ADVISORY RESEARCH INC |
13F
Company
|
0.59%
|
$175,505
257,225 shares
|
— | 30 Jun 2025 |
| STIFEL FINANCIAL CORP |
13F
Company
|
0.45%
|
$134,110
196,556 shares
|
— | 30 Jun 2025 |
| STATE STREET CORP |
13F
Company
|
0.44%
|
$129,468
189,753 shares
|
— | 30 Jun 2025 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.36%
|
$105,240
154,243 shares
|
— | 30 Jun 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.31%
|
$91,063
133,464 shares
|
— | 30 Jun 2025 |
| NORTHERN TRUST CORP |
13F
Company
|
0.31%
|
$90,455
132,573 shares
|
— | 30 Jun 2025 |
| ANGELES WEALTH MANAGEMENT, LLC |
13F
Company
|
0.28%
|
$81,876
120,000 shares
|
— | 30 Jun 2025 |
| Chicago Partners Investment Group LLC |
13F
Company
|
0.2%
|
$78,589
88,302 shares
|
— | 30 Jun 2025 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
Company
|
0.19%
|
$56,631
83,000 shares
|
— | 30 Jun 2025 |
| LPL Financial LLC |
13F
Company
|
0.14%
|
$40,522
59,390 shares
|
— | 30 Jun 2025 |
| Sigma Planning Corp |
13F
Company
|
0.13%
|
$37,868
55,500 shares
|
— | 30 Jun 2025 |
| Texas Capital Bank Wealth Management Services Inc |
13F
Company
|
0.08%
|
$22,585
33,102 shares
|
— | 30 Jun 2025 |
| MORGAN STANLEY |
13F
Company
|
0.07%
|
$20,096
29,452 shares
|
— | 30 Jun 2025 |
| Navalign, LLC |
13F
Company
|
0.06%
|
$17,058
25,000 shares
|
— | 30 Jun 2025 |
| XTX Topco Ltd |
13F
Company
|
0.05%
|
$15,347
22,493 shares
|
— | 30 Jun 2025 |
| Virtu Financial LLC |
13F
Company
|
0.05%
|
$14,000
20,667 shares
|
— | 30 Jun 2025 |
| Cambridge Investment Research Advisors, Inc. |
13F
Company
|
0.05%
|
$14,000
20,000 shares
|
— | 30 Jun 2025 |
| NewEdge Advisors, LLC |
13F
Company
|
0.05%
|
$13,646
20,000 shares
|
— | 30 Jun 2025 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
0.05%
|
$13,357
19,577 shares
|
— | 30 Jun 2025 |
| PREVAIL INNOVATIVE WEALTH ADVISORS, LLC |
13F
Company
|
0.04%
|
$12,955
18,987 shares
|
— | 30 Jun 2025 |
| Michael Salzhauer |
13F
Individual
|
0.04%
|
$10,917
16,000 shares
|
— | 30 Jun 2025 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
0.03%
|
$9,809
14,376 shares
|
— | 30 Jun 2025 |
| SeaCrest Wealth Management, LLC |
13F
Company
|
0.03%
|
$8,870
13,000 shares
|
— | 30 Jun 2025 |
| HRT FINANCIAL LP |
13F
Company
|
0.03%
|
$8,000
11,812 shares
|
— | 30 Jun 2025 |
| Beacon Pointe Advisors, LLC |
13F
Company
|
0.02%
|
$6,823
10,000 shares
|
— | 30 Jun 2025 |
| JPMORGAN CHASE & CO |
13F
Company
|
0.02%
|
$4,797
7,030 shares
|
— | 30 Jun 2025 |
| BARCLAYS PLC |
13F
Company
|
0.01%
|
$4,114
6,029 shares
|
— | 30 Jun 2025 |
| Gleason Group, Inc. |
13F
Company
|
0.01%
|
$4,094
6,000 shares
|
— | 30 Jun 2025 |
| RAYMOND JAMES FINANCIAL INC |
13F
Company
|
0.01%
|
$2,286
3,350 shares
|
— | 30 Jun 2025 |
| NFSG Corp |
13F
Company
|
0.01%
|
$2,047
3,000 shares
|
— | 30 Jun 2025 |
| Golden State Wealth Management, LLC |
13F
Company
|
0%
|
$1,365
2,000 shares
|
— | 30 Jun 2025 |
| Tidemark, LLC |
13F
Company
|
0%
|
$1,023
1,500 shares
|
— | 30 Jun 2025 |
| Physician Wealth Advisors, Inc. |
13F
Company
|
0%
|
$687
1,006 shares
|
— | 30 Jun 2025 |
| BNP PARIBAS FINANCIAL MARKETS |
13F
Company
|
0%
|
$488
715 shares
|
— | 30 Jun 2025 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
0%
|
$463
680 shares
|
— | 30 Jun 2025 |
| MAI Capital Management |
13F
Company
|
0%
|
$239
350 shares
|
— | 30 Jun 2025 |
| Sunbelt Securities, Inc. |
13F
Company
|
0%
|
$258
237 shares
|
— | 30 Jun 2025 |
| ARMSTRONG ADVISORY GROUP, INC |
13F
Company
|
0%
|
$82
120 shares
|
— | 30 Jun 2025 |
| IFP Advisors, Inc |
13F
Company
|
0%
|
$68
100 shares
|
— | 30 Jun 2025 |
| Michael J. Fox |
3/4/5
Director
|
—
mixed-class rows
|
$3,036,000
1,148,800 shares
mixed-class rows
|
— | 05 Jun 2024 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q3 2025
As of 30 Sep 2025,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,058,960 shares.
The largest 10 holders included
Bleichroeder LP, GC Wealth Management RIA, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, Robertson Stephens Wealth Management, LLC, BlackRock, Inc., BANK OF AMERICA CORP /DE/, ADVISORY RESEARCH INC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
46
Q3 2025 holders
52
Holder diff
6
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.